These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1692259)

  • 1. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
    Dunsford HA; Sell S; Chisari FV
    Cancer Res; 1990 Jun; 50(11):3400-7. PubMed ID: 1692259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice.
    Sell S; Hunt JM; Dunsford HA; Chisari FV
    Cancer Res; 1991 Feb; 51(4):1278-85. PubMed ID: 1847661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.
    Huang SN; Chisari FV
    Hepatology; 1995 Mar; 21(3):620-6. PubMed ID: 7875658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
    Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
    Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
    Koike K; Moriya K; Iino S; Yotsuyanagi H; Endo Y; Miyamura T; Kurokawa K
    Hepatology; 1994 Apr; 19(4):810-9. PubMed ID: 8138251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
    Jakubczak JL; Chisari FV; Merlino G
    Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
    Ghebranious N; Sell S
    Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis and hepatocarcinogenesis in the transgenic mice].
    Hino O
    Nihon Rinsho; 1993 Feb; 51(2):531-5. PubMed ID: 8464165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic preneoplasia in hepatitis B virus transgenic mice.
    Toshkov I; Chisari FV; Bannasch P
    Hepatology; 1994 Nov; 20(5):1162-72. PubMed ID: 7927248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
    Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
    Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models to study the interaction of risk factors for human liver cancer.
    Sell S
    Cancer Res; 2003 Nov; 63(22):7553-62. PubMed ID: 14633666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBx gene of hepatitis B virus induces liver cancer in transgenic mice.
    Kim CM; Koike K; Saito I; Miyamura T; Jay G
    Nature; 1991 May; 351(6324):317-20. PubMed ID: 2034275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of intrahepatic lymphocyte subsets in a transgenic mouse model of immune-mediated hepatocarcinogenesis.
    Nakamoto Y; Kaneko S
    J Exp Clin Cancer Res; 2006 Mar; 25(1):55-7. PubMed ID: 16761618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.